Globalization has put cost-competitive therapeutics in the hands of patients around the world. It has also made the biopharmaceutical industry more vulnerable to dubious sourcing and manufacturing practices, supply chain disruptions and tighter regulatory control. A well-defined risk management strategy can help life sciences companies protect both their supply chains and the end patients. This paper describes the four critical success factors for achieving supply chain risk management excellence while ensuring consumer safety in the life sciences industry. Practical real-world supply chain risk management case study scenarios are described in support of these critical success factors.
This white paper will discuss:
- How to map your supply chain to achieve end-to-end supplier visibility
- Implementing pro-active supply chain risk management strategies
- The importance of 'unobvious' supply chain risks and events, and how to monitor and react to them
- How to leverage automation to help meet regulatory requirements